ijms-logo

Journal Browser

Journal Browser

Cancer Stem Cells—Biological Properties and Therapeutic Approaches

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Biochemistry".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 20

Special Issue Editor


E-Mail Website
Guest Editor
Laboratory of Biology of Stem and Neoplastic Cells, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland
Interests: mesenchymal stem cells (MSCs); MSCs secretome; regenerative medicine; cellular therapy; muscular dystrophy; wound healing; cancer cell biology; cancer stem cells (CSCs)
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cancer stem cells (CSCs) represent a subpopulation of cancer cells with distinct stem-like properties, such as self-renewal and multipotency, and are responsible for tumor initiation, proliferation, invasive growth, heterogeneity, resistance to chemotherapy, and cancer metastasis. CSCs, in addition to the tumor-specific phenotype, are characterized by the presence of markers different from those of mature cancer cells. Extensive research in the area of CSCs has been targeted at identifying markers specific to the CSCs responsible for the development of various types of cancer. The features of CSCs are also associated with the expression of pluripotent genes and the role of transcriptional factors related to pluripotency and cell differentiation. Therefore, understanding and regulating CSC transcription factors is an important prerequisite for eliminating cancer stemness properties and promoting cancer cell destruction. This Special Issue will focus on several topics to fill in the missing gaps related to the biological characteristics of CSCs, such as their gene expression profile, cell cycle, apoptosis, microenvironment, phenotype, and sensitivity to therapeutic agents. Recognizing the specific biological features of CSCs at the gene and protein-expression level will provide new insights toward the identification of a new target for CSC-based therapeutic interventions, so research in this area will be very welcome in this Special Issue.

Prof. Dr. Aleksandra Klimczak
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer stem cells (CSCs)
  • cancer cell biology
  • gene expression
  • CSCs and microenvironment
  • signalling pathway
  • therapeutic sensitivity
  • cellular therapy
  • CSCs heterogeneity
  • cancer cell metabolism
  • molecular target of CSCs
  • targeted therapy
  • cancer relapse

Published Papers

This special issue is now open for submission.
Back to TopTop